I had an alert come in yesterday that Caremark is bringing BD pen needles and insuling syringes into their preferred formulary lists. A formulary is a list of medications that your insurance plan will cover, and specifies varies drugs that are "preferred", and you can obtain for lower prices. I have a lot of good things to say about the BD brand.
You can read it here:
WhoTrades: CVS/Caremark Moves BD Products To Preferred Formulary
Includes: $CVS $BDX $NVO
Further Reading:
Seeking Alpha: They're Definitely High On Something
Includes: $PFE $MRK $TEVA $MYL $SPY $IBB $LABU $CELG $BIIB $GILD $AMGN $REGN $ALXN $INCY $VRTX $ILMN $SRPT $IINX $ICPT $BLUE $TSRO $JUNO $ARIA $MGLN $CVS $TGT $NVO
Also, I have an update on one of the Life Cross sell recommendations:
The chart can't catch everything, but it is a work in progress. The Life Cross gave a sell rating on Mercadolibre only a few short weeks ago, and it turned out that may have been too soon, as the company brought in a solid earnings beat yesterday.
That said, I still think there's added risk in the high price, but there is more than one way to get your hands on some Mercadolibre ownership at a good price:
WhoTrades: MercadoLibre Beats, But There's A Better Way To Invest
Includes: $MELI $EBAY
